- Home
- / ARCA biopharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
ARCA biopharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$2.4
2024-08-30
Market Capitalization
$34.8 M
2024-08-30
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General and administrative expense | 5.0M | 3.2M | 4.0M | 4.1M | 4.4M | 4.3M | 4.6M | 3.9M | 4.0M | 4.8M | 5.5M | 5.8M | 6.3M | 13.1M | 21.4M |
| Operating expense total | 7.4M | 4.3M | 6.9M | 9.7M | 11.5M | 16.6M | 18.7M | 8.1M | 5.8M | 9.8M | 10.6M | 7.3M | 88.1M | 122.1M | |
| EBIT | (7.4M) | (4.3M) | (6.9M) | (9.7M) | (11.5M) | (16.6M) | (18.7M) | (8.1M) | (5.8M) | (9.8M) | (19.3M) | (10.6M) | (7.3M) | (88.1M) | (122.1M) |
| Interest income | 2.0K | 2.0K | 5.0K | 7.0K | 14.0K | 169.0K | 167.0K | 162.0K | 172.0K | 28.0K | 13.0K | 675.0K | 2.0M | 5.9M | 16.6M |
| Interest expense | 5.0K | 3.0K | 9.0K | ||||||||||||
| Pre tax profit | (5.4M) | (4.3M) | (6.9M) | (18.6M) | (8.0M) | (5.6M) | (9.7M) | (19.3M) | (83.7M) | (105.4M) | |||||
| Income tax expense | (61.0K) | (31.0K) | (167.0K) | (9.0K) | |||||||||||
| Net Income | (5.4M) | (4.3M) | (6.9M) | (9.7M) | (11.4M) | (16.4M) | (18.5M) | (7.9M) | (5.5M) | (9.7M) | (19.3M) | (9.9M) | (5.3M) | (83.7M) | (105.4M) |
| EPS | (0.7) | (0.4) | (3.9) |